Annual Total Debt
$50.67 M
-$333.00 K-0.65%
December 31, 2023
Summary
- As of February 12, 2025, RXRX annual total debt is $50.67 million, with the most recent change of -$333.00 thousand (-0.65%) on December 31, 2023.
- During the last 3 years, RXRX annual total debt has risen by +$35.01 million (+223.53%).
- RXRX annual total debt is now -0.65% below its all-time high of $51.01 million, reached on December 31, 2022.
Performance
RXRX Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$90.63 M
+$749.00 K+0.83%
September 30, 2024
Summary
- As of February 12, 2025, RXRX quarterly total debt is $90.63 million, with the most recent change of +$749.00 thousand (+0.83%) on September 30, 2024.
- Over the past year, RXRX quarterly total debt has increased by +$39.65 million (+77.79%).
- RXRX quarterly total debt is now at all-time high.
Performance
RXRX Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
RXRX Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -0.7% | +77.8% |
| 3 y3 years | +223.5% | +77.7% |
| 5 y5 years | +213.4% | +77.7% |
RXRX Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -0.7% | +341.5% | at high | +689.5% |
| 5 y | 5-year | -0.7% | +341.5% | at high | -100.0% |
| alltime | all time | -0.7% | +341.5% | at high | -100.0% |
Recursion Pharmaceuticals Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $90.63 M(+0.8%) |
| Jun 2024 | - | $89.88 M(+76.3%) |
| Mar 2024 | - | $50.97 M(+0.6%) |
| Dec 2023 | $50.67 M(-0.7%) | $50.67 M(-1.6%) |
| Sep 2023 | - | $51.48 M(-2.7%) |
| Jun 2023 | - | $52.90 M(-0.3%) |
| Mar 2023 | - | $53.05 M(+4.0%) |
| Dec 2022 | $51.01 M | $51.01 M(-2.3%) |
| Sep 2022 | - | $52.19 M(-2.8%) |
| Jun 2022 | - | $53.68 M(+3.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $52.10 M(+354.0%) |
| Dec 2021 | $11.48 M(-26.7%) | $11.48 M(+104.2%) |
| Sep 2021 | - | $5.62 M(-63.7%) |
| Jun 2021 | - | $15.48 M(-0.3%) |
| Mar 2021 | - | $15.54 M(-0.8%) |
| Dec 2020 | $15.66 M(-3.1%) | - |
| Dec 2020 | - | $15.66 M(>+9900.0%) |
| Sep 2020 | - | $0.00(0.0%) |
| Jun 2020 | - | $0.00(0.0%) |
| Mar 2020 | - | $0.00 |
| Dec 2019 | $16.17 M | - |
FAQ
- What is Recursion Pharmaceuticals annual total debt?
- What is the all time high annual total debt for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals annual total debt year-on-year change?
- What is Recursion Pharmaceuticals quarterly total debt?
- What is the all time high quarterly total debt for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals quarterly total debt year-on-year change?
What is Recursion Pharmaceuticals annual total debt?
The current annual total debt of RXRX is $50.67 M
What is the all time high annual total debt for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high annual total debt is $51.01 M
What is Recursion Pharmaceuticals annual total debt year-on-year change?
Over the past year, RXRX annual total debt has changed by -$333.00 K (-0.65%)
What is Recursion Pharmaceuticals quarterly total debt?
The current quarterly total debt of RXRX is $90.63 M
What is the all time high quarterly total debt for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high quarterly total debt is $90.63 M
What is Recursion Pharmaceuticals quarterly total debt year-on-year change?
Over the past year, RXRX quarterly total debt has changed by +$39.65 M (+77.79%)